VCM
TARS icon

Voleon Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Voleon Capital Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.73M Sell
43,405
-25,530
-37% -$1.63M 0.05% 304
2026
Q1 		$4.84M Sell
68,935
-8,440
-11% -$590K 0.1% 205
2025
Q4 		$6.34M Buy
77,375
+54,392
+237% +$4.06M 0.14% 171
2025
Q3 		$1.37M Buy
+22,983
New +$1.13M 0.03% 367
2025
Q1 		– Sell
-5,266
Closed -$292K – 409
2024
Q4 		$292K Buy
+5,266
New +$239K 0.02% 289

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Voleon Capital Management's TARS Position: Q2 2026 in Review

Voleon Capital Management reduced its Tarsus Pharmaceuticals (TARS) stake by 37% in Q2 2026, selling an estimated $1.63M and leaving 43,405 shares worth $2.73M. The position accounts for 0.05% of the portfolio, ranked #304.

Voleon Capital Management first reported a position in TARS in Q4 2024 and has held it in 5 quarters since. The position peaked at $6.34M in Q4 2025. 256 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Voleon Capital Management held 43,405 shares of Tarsus Pharmaceuticals worth $2.73M as of Q2 2026.
  • Voleon Capital Management sold 25,530 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $1.63M.
  • Tarsus Pharmaceuticals made up 0.05% of Voleon Capital Management's portfolio in Q2 2026, its #304 holding.
  • Voleon Capital Management first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • Voleon Capital Management's Tarsus Pharmaceuticals position peaked at $6.34M in Q4 2025.
  • 256 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.